Article Details

GSK to acquire clinical-stage biopharmaceutical company Affinivax - Labiotech.eu

Retrieved on: 2022-06-01 14:30:53

Tags for this article:

Click the tags to see associated articles and topics

GSK to acquire clinical-stage biopharmaceutical company Affinivax - Labiotech.eu. View article details on hiswai:

Excerpt

GSK is set to acquire Affinivax, a biopharma company in Cambridge, Massachusetts, for a $2.1B upfront payment and up to $1.2B in potential ...

Article found on: www.labiotech.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up